Skip to main content
Caplight Logo









BloomText

BloomText

Private
Seattle, WashingtonHealthcare & Life Scienceshttps://www.bloomtext.com/

Last Round

Seed

Jul 13, 2017

Est. Valuation

$1.71M

Total Funding Raised

$2.52M

Company Overview

BloomText operates in Healthcare & Life Sciences and is based in Seattle, Washington. Its latest recorded funding round was a Seed round in July 2017.

BloomText is a healthcare software company that provides a secure, HIPAA-compliant communication platform for healthcare organizations to communicate with patients, clients, and staff.

Sector

Healthcare & Life Sciences

Verticals

Enterprise Communication, Compliance, Cloud Communications

Business Model

B2B

Customer Profile

Subscription SaaS, Freemium

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

BloomText Comparables

Compare BloomText with similar companies based on industry and business-model similarity.

BloomText comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
QliqSOFT
81%
Spruce Health
79%
OhMD
79%
Book a demo to see all comparables

For institutional investors. Book with your work email.

BloomText Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedJul 13, 2017
AcceleratorMar 1, 2017
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

BloomText Investors

Notable investors and investment history

BloomText investors
InvestorRounds
Slow VenturesSeed
S32Seed
Founders' Co-opSeed
NewDo VentureSeed
Y CombinatorSeed, Accelerator
Liquid 2 VenturesSeed
Fifty YearsSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 18, 2026

    Monthly visitors increased 36% MoM to 30.6K.

Book a demo to see all signals

For institutional investors. Book with your work email.

BloomText Filings

Explore SEC and related filing metadata, where available.

BloomText filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about BloomText's valuation, stock price, and market status.

Is BloomText a public or private company?

BloomText is a private company.

What is the current stock price of BloomText?

BloomText is a private company, so its shares have no public market price. Caplight tracks BloomText's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is BloomText worth (valuation)?

BloomText's valuation is estimated at $1.7M based on funding round data.

Can I buy BloomText stock?

BloomText shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was BloomText's last funding round?

BloomText's most recent funding round was Seed on July 13, 2017.

Who are the main investors in BloomText?

Key investors in BloomText include Y Combinator.

Will BloomText IPO soon?

No public IPO plans have been announced for BloomText.

How can I track BloomText secondary market activity?

Caplight tracks bids, offers, and trades in BloomText's shares on secondary markets.

Firmographic Details

HeadquartersSeattle, Washington
Employee Range3
Year Founded2015
Last FundingJul 13, 2017

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?